Liposomes and niosomes as potential carriers for dermal delivery of minoxidil

References

• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14: 101–114
   PubMed Web of Science ®Google Scholar
• Brzezinska-Wcislo L. Effect of minoxidil on hair growth in androgenic alopecia in women. Pol Merkuriusz Lek 2002; 13: 208–211
   PubMedGoogle Scholar
• Budai M, Szogyi M. Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes. Acta Pharm Hung 2001; 71: 114–118
   PubMedGoogle Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004; 56: 675–711
   PubMed Web of Science ®Google Scholar
• Ciotti NS, Weiner N. Follicular liposomal delivery systems. J Liposome Res 2002; 12: 143–148
   PubMed Web of Science ®Google Scholar
• Dargie HJ, Dollery CT, Daniel J. Minoxidil in resistant hypertension. Lancet 1977; 310: 515–518
   Google Scholar
• Davis AF, Gyurik RJ, Hadgraft J, Pellett MA, Walters KA. Formulation strategies for modulating skin permeation. Dermatological and transdermal formulations, KA Walters. Marcel Dekker Inc, New York 2002; 271–317
   Google Scholar
• Du Plessis J, Ramachandran C, Weiner N, Muller DG. The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 1994; 103: 277–282
   Web of Science ®Google Scholar
• Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 1993; 32: 758–762
   PubMed Web of Science ®Google Scholar
• Kirby C, Gregoriadis G. Dehydration-rehydration vesicles (DRV): A new method for high yield drug entrapment in liposomes. Biotechnology 1984; 11: 979–984
   Google Scholar
• Kreindler TG. Topical minoxidil in early androgenetic alopecia. J Am Acad Dermatol 1987; 16: 718–724
   PubMed Web of Science ®Google Scholar
• Lauer AC, Ramachandran C, Lieb LM, Niemes S, Weiner ND. Targeted delivery to pilosebaceous unit via liposomes. Adv Drug Deliv Rev 1996; 18: 311–324
   Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006; 311: 11–19
   PubMed Web of Science ®Google Scholar
• Messenger A. Minoxidil: Mechanism of action on hair growth. Br J Dermatol 2004; 150: 186–194
   PubMed Web of Science ®Google Scholar
• Mezei M. Liposomes in the topical application of drugs. Liposomes as drug carriers, G Gregoriadis. John Wiley & Sons Ltd, New York 1988; 663–677
   Google Scholar
• Mezei M. Biodisposition of liposome-encapsulated active ingredients applied on the skin. Liposome dermatics, O Braun-Falco, HC Korting, HI Maibach. Springer-Verlag, Berlin, Germany 1992; 206–214
   Google Scholar
• Mezei M. Liposomes and the skin. Liposomes in drug delivery, G Gregoriadis, AT Florence, H Patel. Harwood Academic Publishers, Chur, Switzerland 1993; 124–135
   Google Scholar
• Mezei M, Gulasekharam V. Liposomes: A selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980; 26: 1473–1477
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulasekharam V. Liposomes a selective drug delivery system for the topical route of administration: Gel dosage form. J Pharm Pharmacol 1982; 34: 473–474
   PubMed Web of Science ®Google Scholar
• Olsen EA, Weiner MS. Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment. J Am Acad Dermatol 1987; 17: 97–101
   PubMed Web of Science ®Google Scholar
• Olsen EA, Weiner MS, Amara IA, DeLong ER. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol 1990; 22: 643–646
   PubMed Web of Science ®Google Scholar
• Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377–385
   PubMed Web of Science ®Google Scholar
• Block copolymer nanoparticle for follicular delivery of hair drugs. Fourth intercontinental meeting of hair research societies abstracts, WS Park, JW Shim, DS Sung, DK Kim, CH Lee, YC Shim, 2004; P1–P10, June 17–19; Berlin, Germany
   Google Scholar
• Patel HM, Moghimi SM. Liposomes and the skin permeability barrier. Liposomes in drug delivery, G Gregoriadis, AT Florence, HM Patel. Harwood Academic Publishers, Chur, Switzerland 1993; 142–146
   Google Scholar
• Pavithran K. Erythema multiforme following topical minoxidil. Indian J Dermatol Venereol Leprol 1993; 59: 313–314
   Google Scholar
• Rumsfield JA, West DP, Fiedler-Weiss VC. Topical minoxidil therapy for hair regrowth. Clin Pharm 1987; 6: 386–392
   PubMedGoogle Scholar
• Sentjurc M, Vrhovnik K, Kristl J. Liposomes as a topical delivery system: The role of size on transport studied by the EPR imaging method. J Control Release 1999; 59: 87–97
   PubMed Web of Science ®Google Scholar
• Shim J, Seok Kang H, Park WS, Han SH, Kim J, Chang IS. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release 2004; 97: 477–484
   PubMed Web of Science ®Google Scholar
• Shupack JL, Kassimir JJ, Thirumoorthy T, Reed ML, Jondreau L. Dose-response study of topical minoxidil in male pattern alopecia. J Am Acad Dermatol 1987; 16: 673–676
   PubMed Web of Science ®Google Scholar
• Sinclair RD. Male androgenetic alopecia (Part II). J Mens Health Gend 2005; 2: 38–44
   Google Scholar
• Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes as carriers for dermal delivery of tretinoin: In vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release 2005; 103: 123–136
   PubMed Web of Science ®Google Scholar
• Sinico C, Valenti D, Manconi M, Lai F, Fadda AM. Cutaneous delivery of 8-methoxypsoralen from liposomal and niosomal carriers. J Drug Deliv Sci Technol 2006; 16: 115–120
   Web of Science ®Google Scholar
• Surber C, Davis AF. Bioavailability and bioequivalence of dermatological formulations. Dermatological and transdermal formulations, KA Walters. Marcel Dekker Inc, New York 2002; 401–498
   Google Scholar
• Swales JD, Heagerty A, Russell GI, Bing RF, Pohl JEF, Thurston H. Treatment of refractory hypertension. Lancet 1982; 319: 894–896
   Google Scholar
• Tata S, Flynn GL, Weiner ND. Penetration of minoxidil from ethanol/propylene glycol solutions: Effect of application volume and occlusion. J Pharm Sci 1995; 84: 688–691
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Liposomes as carriers for topical and transdermal delivery. J Pharm Sci 1994; 83: 1189–1203
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003a; 258: 141–151
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: A skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 2003b; 55: 271–277
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancer. Adv Drug Deliv Rev 2004; 56: 603–618
   PubMed Web of Science ®Google Scholar
• Zappacosta A. Reversal of baldness in patient receiving minoxidil for hypertension. N Engl J Med 1980; 303: 1480–1481
   PubMed Web of Science ®Google Scholar
• Zellmer S, Pfiel W, Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta 1995; 237: 176–182
   Web of Science ®Google Scholar